Report Detail
Global Insulin Market Growth 2019-2024
- RnM2872640 |
- 04 February, 2019 |
- Global |
- 136 Pages |
- LPI(LP Information) |
- Other
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
There are three type of insulin by resource, it is animal insulin, human insulin, insulin analogue. Animal insulin, because of its side effects, the market share of it is less than 10%, and in the future, the market share will be decrease continually. Human insulin has a larger consumption than insulin analogue, but the side effect is bigger than insulin analogue, so the future market will be occupied by insulin analogue. At the same time, the biggest company producing insulin, Novo Nordisk, has developed a new kind insulin recently, so it will also has a market share in the future.
According to this study, over the next five years the Insulin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin market by product type, application, key manufacturers and key regions and countries.
This study considers the Insulin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Insulin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Insulin market by identifying its various subsegments.
Focuses on the key global Insulin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Insulin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Insulin Consumption 2014-2024
- 2.1.2 Insulin Consumption CAGR by Region
- 2.2 Insulin Segment by Type
- 2.2.1 Animal Insulin
- 2.2.2 Regular Human Insulin
- 2.2.3 Insulin Analogue
- 2.3 Insulin Consumption by Type
- 2.3.1 Global Insulin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Insulin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Insulin Sale Price by Type (2014-2019)
- 2.4 Insulin Segment by Application
- 2.4.1 Short acting
- 2.4.2 Intermediate acting
- 2.4.3 Long acting
- 2.4.4 Pre-mix Insulin
- 2.5 Insulin Consumption by Application
- 2.5.1 Global Insulin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Insulin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Insulin Sale Price by Application (2014-2019)
3 Global Insulin by Players
- 3.1 Global Insulin Sales Market Share by Players
- 3.1.1 Global Insulin Sales by Players (2017-2019)
- 3.1.2 Global Insulin Sales Market Share by Players (2017-2019)
- 3.2 Global Insulin Revenue Market Share by Players
- 3.2.1 Global Insulin Revenue by Players (2017-2019)
- 3.2.2 Global Insulin Revenue Market Share by Players (2017-2019)
- 3.3 Global Insulin Sale Price by Players
- 3.4 Global Insulin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Insulin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Insulin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Insulin by Regions
- 4.1 Insulin by Regions
- 4.1.1 Global Insulin Consumption by Regions
- 4.1.2 Global Insulin Value by Regions
- 4.2 Americas Insulin Consumption Growth
- 4.3 APAC Insulin Consumption Growth
- 4.4 Europe Insulin Consumption Growth
- 4.5 Middle East & Africa Insulin Consumption Growth
5 Americas
- 5.1 Americas Insulin Consumption by Countries
- 5.1.1 Americas Insulin Consumption by Countries (2014-2019)
- 5.1.2 Americas Insulin Value by Countries (2014-2019)
- 5.2 Americas Insulin Consumption by Type
- 5.3 Americas Insulin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Insulin Consumption by Countries
- 6.1.1 APAC Insulin Consumption by Countries (2014-2019)
- 6.1.2 APAC Insulin Value by Countries (2014-2019)
- 6.2 APAC Insulin Consumption by Type
- 6.3 APAC Insulin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Insulin by Countries
- 7.1.1 Europe Insulin Consumption by Countries (2014-2019)
- 7.1.2 Europe Insulin Value by Countries (2014-2019)
- 7.2 Europe Insulin Consumption by Type
- 7.3 Europe Insulin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Insulin by Countries
- 8.1.1 Middle East & Africa Insulin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Insulin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Insulin Consumption by Type
- 8.3 Middle East & Africa Insulin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Insulin Distributors
- 10.3 Insulin Customer
11 Global Insulin Market Forecast
- 11.1 Global Insulin Consumption Forecast (2019-2024)
- 11.2 Global Insulin Forecast by Regions
- 11.2.1 Global Insulin Forecast by Regions (2019-2024)
- 11.2.2 Global Insulin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Insulin Forecast by Type
- 11.8 Global Insulin Forecast by Application
12 Key Players Analysis
- 12.1 Novo Nordisk
- 12.1.1 Company Details
- 12.1.2 Insulin Product Offered
- 12.1.3 Novo Nordisk Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novo Nordisk News
- 12.2 Eli Lilly
- 12.2.1 Company Details
- 12.2.2 Insulin Product Offered
- 12.2.3 Eli Lilly Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Eli Lilly News
- 12.3 Sanofi-Aventis
- 12.3.1 Company Details
- 12.3.2 Insulin Product Offered
- 12.3.3 Sanofi-Aventis Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Sanofi-Aventis News
- 12.4 Tonghua Dongbao
- 12.4.1 Company Details
- 12.4.2 Insulin Product Offered
- 12.4.3 Tonghua Dongbao Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Tonghua Dongbao News
- 12.5 Ganlee
- 12.5.1 Company Details
- 12.5.2 Insulin Product Offered
- 12.5.3 Ganlee Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Ganlee News
- 12.6 United Laboratory
- 12.6.1 Company Details
- 12.6.2 Insulin Product Offered
- 12.6.3 United Laboratory Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 United Laboratory News
- 12.7 Jiangsu Wanbang
- 12.7.1 Company Details
- 12.7.2 Insulin Product Offered
- 12.7.3 Jiangsu Wanbang Insulin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Jiangsu Wanbang News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Insulin . Industry analysis & Market Report on Insulin is a syndicated market report, published as Global Insulin Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Insulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
